Collected Dataset / ICoVVaC_CohortB_12months_postdose3

ICoVVaC_CohortB_12months_postdose3
  1. Home
  2. Collected Datasets
  3. ICoVVaC_CohortB_12months_postdose3

ICoVVaC_CohortB_12months_postdose3

Networks -
Variables -
Associated study ICoVVaC Contingency Table

Population

ICoVVaC - Cohort B
The population is composed of cancer patients with solid tumours from cancer clinics at the Ottawa Hospital and at Vancouver BC Cancer, who were not on chemotherapy and who are going to receive COVID-19 vaccination as part of the national vaccine roll-out (standard of care) and included in the study within 4 weeks of the second dose of vaccine.
More info

Data Collection Event

ICoVVaC - Cohort B - 12 months post-dose 3
Information on vaccine information and assessment of clinical outcomes (incidence of COVID-19) was collected. Blood (serum and peripheral blood mononuclear cells (PBMCs) samples were collected.
More info